AbbVie
ABBV
#29
Rank
โ‚น34.251 T
Marketcap
โ‚น19,371
Share price
-5.20%
Change (1 day)
5.78%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): โ‚น143.94 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น59.64 Billion. In 2024 the company made an earning of โ‚น345.50 Billion a decrease over its 2023 earnings that were of โ‚น581.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น143.94 B-58.34%
2024 โ‚น345.50 B-40.54%
2023 โ‚น581.11 B-53.62%
2022 โ‚น1.253 T3.76%
2021 โ‚น1.207 T282.25%
2020 โ‚น315.94 B-59.67%
2019 โ‚น783.44 B62.13%
2018 โ‚น483.21 B-32.74%
2017 โ‚น718.44 B-1.99%
2016 โ‚น733.04 B18.65%
2015 โ‚น617.84 B180.5%
2014 โ‚น220.26 B-55.57%
2013 โ‚น495.76 B-6.86%
2012 โ‚น532.29 B56.05%
2011 โ‚น341.09 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.101 T 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.092 T 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น766.51 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น177.03 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น919.19 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น746.90 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น1.217 T 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น866.83 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚น54.22 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA